Science
Mechanism of Action
Functions as a selective Protein Kinase A inhibitor that disrupts melanin production by acidifying melanosome pH and preventing melanosome maturation. Since tyrosinase enzyme requires neutral pH conditions to remain active, this acidification effectively halts melanin synthesis and blocks the progression from pre-melanosomes to fully pigmented mature melanosomes.
Research
Clinical Evidence
High confidence0.00067%
Transparency
Dusting Analysis
With proven efficacy at 0.00067%, any concentration below 0.001% should be scrutinized for potential dusting, as the therapeutic window is extremely narrow for this potent ingredient.
The Formula
Formulation
Stability
Demonstrates excellent stability across a broad pH range from acidic to neutral conditions. Particularly stable when formulated with AHAs in acidic environments (pH 3.5-4.5) and compatible with niacinamide in neutral formulations (pH 5.0-7.0). Supplied as hydrochloride salt for enhanced water solubility.
Synergies
- AHAs
- niacinamide
Safety
Safety Profile
Demonstrates excellent tolerance profile suitable for sensitive areas including eye contour and intimate zones. No documented adverse reactions or regulatory restrictions from SCCS or FDA.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A scientifically-backed depigmenting agent with exceptional potency at ultra-low concentrations, though limited clinical data restricts it from essential status.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources